Company Overview and News

10
Market Snapshot: Dow poised to jump 100 points at the open as stock market aims to follow China rebound

18h marketwatch
U.S. stocks appeared set to kick of Friday trade solidly higher as a rebound in China’s main equity benchmarks assuaged dread about waning global growth, even as Beijing reported the worst rate of economic expansion since 2009.
AVF PYPL AIG 8685 DWDP

17
Trump administration releases Prudential from strict post-crisis oversight

2018-10-19 sfgate
WASHINGTON — The Trump administration said Wednesday that Prudential Financial, the giant insurer, would no longer be subject to stricter federal oversight, bringing to zero the number of financial firms outside the banking system that face such scrutiny.
PRU GEC GE AVF PRH PFK GNE AIG 8685 PJH

4
AIG / American International Group, Inc. FORM 8-K (Current Report)

2018-10-19 sec.gov - 2
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
AIG

17
Prudential Financial shakes off government's 'too-big-to-fail' label

2018-10-17 cnbc
The last of the four nonbank financial companies to bear the label "systemically important" has won relief from stricter regulatory oversight.
PRU GEC GE AVF PRH PFK GNE AIG 8685 PJH

17
US rescinds Prudential’s ‘too-big-to-fail’ designation

2018-10-17 malaymail
WASHINGTON, Oct 17 — US regulators today removed insurance giant Prudential Financial from the list of financial institutions that are deemed “systemically important” and placed under heightened government supervision.
PRU GEC GE AVF PRH PFK GNE AIG 8685 PJH

20
Prudential sheds too big to fail tag, ending tough oversight

2018-10-17 theedgemarkets
(Oct 17): U.S. regulators agreed to drop Prudential Financial Inc’s label as too big to fail, making it the last non-bank to escape a post-crisis designation that subjected firms to extra oversight.
PRU GEC GE AVF PFK MET AIG MET PRH GNE 8685 PJH

20
US seen likely to relieve Prudential of 'systemic' oversight

2018-10-17 channelnewsasia
A panel of U.S. regulators is seen as likely to relieve Prudential Financial Inc from stricter oversight when it meets on Tuesday, in a move that could reduce the insurance company's regulatory costs.
PRU GEC GE AVF PFK MET AIG MET PRH GNE 8685 PJH

20
U.S. seen likely to relieve Prudential of 'systemic' oversight

2018-10-16 reuters
WASHINGTON, Oct 16 (Reuters) - A panel of U.S. regulators is seen as likely to relieve Prudential Financial Inc from stricter oversight when it meets on Tuesday, in a move that could reduce the insurance company’s regulatory costs.
PRU GEC GE AVF PFK MET AIG MET PRH GNE 8685 PJH

2
Nikkei ends higher on robust Chinese exports, rising U.S. stock futures

2018-10-12 reuters
TOKYO, Oct 12 (Reuters) - Japan’s Nikkei changed course and ended higher on Friday as investors took heart from gains in Chinese shares on upbeat Chinese export data, triggering buying in manufacturers exposed to China.
PRU AVF PFK YASKY AIG 6506 PRH 8750 8630 8685 PJH YASKF

2
Nikkei extends slide as investors shun risk; insurers sold

2018-10-12 reuters
TOKYO, Oct 12 (Reuters) - Japan’s Nikkei fell on Friday morning as investors maintained their risk aversion after Wall Street extended its slide overnight, dragging down recent winners such as insurers.
9021 PRU 9020 AVF PRH PFK AIG 8750 8630 8685 PJH

2
A Familial Influence On Protective Insurance

2018-10-08 seekingalpha
Protective Insurance has changed its name, changed its executive team and is executing on a strategic plan that is delivering results.
FXFLF AVF FXFHF FAXXF FDX AIG FRFHF FRFGF FRFFF FRFZF FAXRF FRFXF 8685

13
Fixed Rate Preferred Stocks - Complete Review

2018-10-03 seekingalpha - 4
In this article, I'll review the most popular fixed-income securities, the fixed-rate preferred stocks, sorted into several categories. There are 359 issues in our database that trade on primary exchanges, excluding the convertible preferred stocks, half of which are part of the biggest ETF for fixed-income securities: iShares U.S. Preferred Stock ETF (PFF). As we can see in the chart below, half of the PFF's market capitalization consists of fixed-rate preferred stocks, which also corresponds to almost 60% of the fund's holdings.
VR PFF MHLA AFSS AFST MSPWP MHLD C AIG MPRWL AFSI MPPRD MPRWP

9
Sen. Sanders wants to break up JP Morgan, Berkshire Hathaway and other large financials

2018-10-03 cnbc
Sen. Bernie Sanders wants to break apart giant financial companies including J.P. Morgan Chase, Goldman Sachs and Warren Buffett's conglomerate Berkshire Hathaway, arguing their individual sizes expose the U.S. economy to too much risk.
WFCNP MS 8685 WFC PRU AVF PFK AIG BRK.A PRH PJH

2
Is The 19% Yielding Credit Suisse 2x Leveraged Mortgage REIT ETN A Substitute For The UBS ETRACS Monthly Pay 2x Leveraged Mortgage REIT ETNs?

2018-10-02 seekingalpha
Three 2x Leveraged High-Yield Monthly Pay Mortgage REIT ETNs all have very high yields, but at times may trade at prices which may present risk-free arbitrage opportunities.
SLDA DTK RC ABRN REM CMO TWO 8685 GPMT AJXA HASI ABR CEFL AVF DX AIG ABRN.CL AJX

12
3 Cyber Insurance Stocks in Focus Post Facebook Breach

2018-10-01 zacks
A cyber-attack on Facebook’s (FB - Free Report) security system last week leaked personal information of more than 50 million account holders worldwide. Hackers exploited the social media network’s “view as” feature to gain access to user accounts. This is the biggest security breach in the social media giant’s 14-year history.
UA EXPE FB 2454 AVF CNA UAA WLTW AIG 8685

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to AIG / American International Group, Inc. on message board site Silicon Investor.

AIG: American Intu0027l Group, Inc AIG: American Intu0027l Group, Inc AIG: American Intu0027l Group, Inc Amer. Intu0027l Group (AIG:NYSE) Amer. Intu0027l Group (AIG:NYSE) Amer. Intu0027l Group (AIG:NYSE)
Just shovel your money straight down the OTC-BB sewer Just shovel your money straight down the OTC-BB sewer Just shovel your money straight down the OTC-BB sewer Paige Innovations (Flatplug) PAG tse Paige Innovations (Flatplug) PAG tse Paige Innovations (Flatplug) PAG tse
Queer Eye For The Straight Guy Queer Eye For The Straight Guy Queer Eye For The Straight Guy Pick John Kerryu0027s Campaign Theme Song Pick John Kerryu0027s Campaign Theme Song Pick John Kerryu0027s Campaign Theme Song
Which City Has The Worst Drivers? Which City Has The Worst Drivers? Which City Has The Worst Drivers? AIGI-Adair International AIGI-Adair International AIGI-Adair International
Adair Intl. Oil and Gas (AIGI) Adair Intl. Oil and Gas (AIGI) Adair Intl. Oil and Gas (AIGI) Security Technologies - Straight Talk Security Technologies - Straight Talk Security Technologies - Straight Talk
CUSIP: 026874784